Asha Nayak-Kapoor

Professor

Asha Nayak-Kapoor

Professor

Academic Appointment(s)

Medical College of Georgia
Department of Medicine: Hematology and Oncology

Bio

Dr. Nayak graduated with a medical degree in 1982 from the Maulana Azad Medical College Delhi University, followed by Internal Medicine Residency at Coney Island Hospital, SUNY, Brooklyn NY. In 1999, Dr. Nayak was awarded the Hematology Fellowship at Coney Island Hospital, SUNY Brooklyn, NY and the Oncology Fellowship with Augusta University in 2002.

  • (706) 721-2505
  • (706) 721-8302
  • CN 5321

Education

  • MBBS, Medicine University of Delhi, 1986

Certifications

  • ACL 2020

  • BLS 2020

  • PHY GA STATE MEDICAL BOARD, 2003

  • ABIMH ABIMH, 2004

  • ABIMMO ABIMMO, 2004

  • ABIM ABIM, 2000

Awards & Honors

  • Exemplary Teaching Award for Medical Students AUMC, 2017

  • Exemplary Teaching Award for Medical Students AUMC, 2016

  • VAMC Merit Award VAMC Augusta , 2013

Courses Taught Most Recent Academic Year

  • GMED 5000

    Basic Clerkship GMED
  • RHON 5000

    Hematology-Oncology
  • GMED 5012

    Hematology/Oncology Extn.
  • RMED 5000

    Medicine

Teaching Interests

Currently Dr. Nayak is an Assistant Professor of Medicine, Department of Hematology / Oncology Department, Augusta University. Dr. Nayak is certified by the American Board of Internal Medicine in Hematology and Oncology Specialties. Dr. Nayak is currently a member of several committees, including Onyx and Bayer Speaker Bureau for Nexavar, MCG Cancer Center Molecular Oncology Programme, and MCG Cancer Center Gastrointestinal Tumor Board Committee.

Scholarship

Selected Recent Publications

  • Restoring FAS Expression via Lipid-Encapsulated FAS DNA Nanoparticle Delivery Is Sufficient to Suppress Colon Tumor Growth In Vivo., 2022
    Journal Article, Academic Journal
  • Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study., 2020
    Journal Article, Academic Journal
  • Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells., 2020
    Journal Article, Academic Journal
  • Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes, 2019
    Journal Article, Academic Journal
  • Analysis of race and gender disparities in mortality trends from patients diagnosed with nasopharyngeal, oropharyngeal and hypopharyngeal cancer from 2000 to 2014., 2019
    Journal Article, Academic Journal

Research Interests

Abstracts that Dr. Nayak has participated in include: Incidence of Red Cell auto-antibodies in Hepatitis C Patients; An Unusual Case of Large Cell Lymphoma in Patients with AIDS.; and Role of Radiochemotherapy in Advanced Biliary Cancers. Publications for Dr. Nayak include: Hepatic Failure caused by Plasma Cell Infiltration in Multiple Myeloma, and Plasmablastic Lymphoma with Small Lymphocytic Lymphoma: Clinicopathologic Features, and Review of the Literature.

Department Service

  • Cancer Committee Member 2019 - Present

  • Trial Review Committee 2018 - Present

  • Gastrointestinal Oncology Multidisciplinary Tumor Board 2010 - Present

  • MCG Cancer Center Molecular Oncology Program 2009 - Present

  • AU Cancer Center Gastrointestinal Tumor Board Committee 2008 - Present

Professional Service

  • Exelixis Hepatocellular Carcinoma Multi-Disciplinary Advisory Board 2018 - Present

  • Professor of Medicine, Division of Hematology/Oncology, Augusta University 2018 - Present

  • Onyx and Bayer Speaker Bureau for Nexavar (Sorafenib) 2009 - Present

Public Service

  • Rotary Club Augusta 2009 - Present

    Role: Guest Speaker
  • Shine for Scott 2009 - Present

    Role: Guest Speaker
  • Bone marrow drive organized at Hindu Temple Society 2008 - Present

  • Free Clinic at Holy Angels Church 2008 - Present